Entresto

Entresto Indications/Uses

sacubitril + valsartan

Manufacturer:

Novartis

Distributor:

Zuellig
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure (NYHA class II-IV) with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization due to heart failure (see Pharmacology: Pharmacodynamics under Actions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in